Immunotherapy Promising for Diabetes: Study | The Scientist Magazine®

In new ground-breaking research The Scientist Magazine, reports on a small clinical trial demonstrates that peptide immunotherapy can halt the progression of early-stage type 1 diabetes.

Source: Immunotherapy Promising for Diabetes: Study | The Scientist Magazine®

This is very much early research but if all goes well the drug could be on the market in five to ten years time. At the moment, those with Type 1 Diabetes must take insulin injections.



Revisited – The Despair Death of the Middle-Aged American – The Atlantic

It’s time to revisit this brilliant Atlantic article on the despair death of the middle-aged American. The article explains simply and graphically why uneducated white Americans are living sicker and dying younger.

Source: The Despair Death of the Middle-Aged American – The Atlantic

Despair deaths from alcohol, suicide and drugs are very much in the news. But if anything matters have got considerably worse since the 2015 Atlantic article. Both drug enforcement and treatment are way behind the curve. But perhaps most alarming is the explosive growth in highly addictive, synthetic opioids that have swamped North American cities and are now increasingly a problem in Europe, especially the UK.

With technology increasingly taking over semi-skilled and unskilled jobs, poor Americans with limited education are increasingly likely to suffer despair deaths.

It’s worth joining the dots and suggesting that the poor, uneducated and unskilled American whites who are at risk of despair deaths also probably voted for Donald Trump. As we have seen over the last six months, Trump has consistently failed to deliver, so we must be ready for a spike in despair deaths.